 |
| Dr Sarah Marshall with ANZMS President, Dr Marianne Tare |
Research Fellow Dr Sarah Marshall
was recognised for her research into preeclampsia recently, taking out the top
prize for young investigators—the Michael Perry invited speaker award—at the
recent Australia New Zealand Microcirculation Society (ANZMS) annual scientific meeting in Queensland.
Dr Marshall
joined the Department of Obstetrics and
Gynaecology, School of Clinical Sciences at Monash Health in June
this year. Her research is focused on establishing whether the pregnancy
hormone relaxin could be a potential treatment for the pregnancy
disorder preeclampsia.
“During this investigation I
established an ex vivo model to replicate the vascular dysfunction of
preeclampsia in a lab setting, eliminating the need for more invasive and
expensive research techniques,” Dr Marshall said.
“The model I have now established
provides us with a new way of assessing whether drugs are capable of
protecting or reversing the widespread vascular dysfunction of women with
preeclampsia.”
“This will enable us to perform
pre-clinical screening of a variety of drugs already known to be safe in
pregnancy, and establish which should be looked into further.”
Dr Marshall said her prize win will
allow her to present her work to an international audience.
As part of her award, Dr Marshall
receives a paid trip to and will be an invited speaker at the 11th World
Congress for Microcirculation in Canada in 2018.
Dr Marshall’s research was
completed at both Monash University and the University Melbourne, in
collaboration with Professor Euan Wallace, Dr Marianne Tare and Professor Laura
Parry.
No comments:
Post a Comment